Kymab Wins UK Supreme Court Antibody Battle Against Regeneron
The UK Supreme Court has supported an appeal by British biotech Kymab to revoke antibody…
30/06/2020 - 4 minutes
Regeneron
Update: Fifth US Antibody Patent Owned by UK Biotech Upheld in Regeneron Battle
Update (04/06/2020): After upholding four of Kymab's patents addressing the production of antibody drugs earlier…
04/06/2020 - 4 minutes
Finnish Genetics Study Provides Clues for Treating Type 2 Diabetes
A genetic mutation common to Finnish populations has been found to protect against type 2…
04/11/2019 - 2 minutes
Dutch and US Biotechs Team Up Against HPV-related Cancer
ISA Pharmaceuticals will work together with Regeneron to combine its immunotherapy against cancer induced by…
18/12/2017 - 2 minutes
Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer
Regeneron and Sanofi have announced positive early results from a Phase II study investigating their…
13/12/2017 - 3 minutes
Update: The EU Approval of Dupixent Might Bring its Pricing Polemic to Europe
Update (01/10/2017): The European Commission has tighter control over pricing that governments have over here…
02/10/2017 - 1 minute
Checkpoint Inhibitor from Regeneron and Sanofi gets Priority After Breakup
The FDA has granted breakthrough therapy designation to Regeneron and Sanofi for cemiplimab, just a…
08/09/2017 - 1 minute
Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials
Bayer's and Regeneron's blockbuster Eylea could be facing serious competition, as Novartis boasts with positive…
20/06/2017 - 2 minutes
Get Ready for One of the Biggest New Drug Approvals of the Year
After Praluent, Sanofi and Regeneron have now scored their next drug approval with dupilumab, an antibody for the…
29/03/2017 - 3 minutes
Which European Blockbusters Topped the Charts in 2016?
Blockbuster drugs are raking in billions each year in sales. Let's have a look at the top…
08/03/2017 - 4 minutes
The 8 Biggest Biotech Medical Fails of 2016 in Europe
Although 2016 has brought plenty of good news in medical advances, biotech is an industry…
23/12/2016 - 5 minutes
UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug
Sanofi and Regeneron (NY, US) have ruled their phase III clinical trial immunotherapy Sarilumab a…
31/10/2016 - 3 minutes
